Biotrin assay to monitor cervical cancer exposure rates.
Explore the source record for details and available documents.
Biological Assay↗
Biomedical subjects
Cormac Sheridan
Publications and source records attributed to Cormac Sheridan.
European pharma consolidation generates quality spinoffs.
Explore the source record for details and available documents.
Commerce↗
Rising biotech appetite in the East.
Explore the source record for details and available documents.
Asia↗
Genentech raises stakes on PARP inhibitors.
Explore the source record for details and available documents.
Drug Evaluation, Preclinical↗
BioXell: an Italian biotech success story?
Explore the source record for details and available documents.
Biotechnology↗
Tysabri back on market.
Explore the source record for details and available documents.
Antibodies, Monoclonal↗
First-in-class cancer therapeutic to stimulate natural killer cells.
Explore the source record for details and available documents.
Animals↗
Diversa restructures, raising question over bioprospecting.
Explore the source record for details and available documents.
Biotechnology↗
Who's who in biotech.
Explore the source record for details and available documents.
Administrative Personnel↗
TeGenero fiasco prompts regulatory rethink.
Explore the source record for details and available documents.
Antibodies, Monoclonal↗
Stem cell controversy to stall European tissue and cell therapy rules.
Explore the source record for details and available documents.
Bioethics↗
Interest heats up in gastrointestinal space.
Explore the source record for details and available documents.
Antibodies, Monoclonal↗
First generic biologics finally approved.
Explore the source record for details and available documents.
Biological Products↗
Budget cuts curb Europe's enthusiasm to revive innovation.
Explore the source record for details and available documents.
Budgets↗
German biotech sector inches forward despite long odds.
Explore the source record for details and available documents.
Biotechnology↗